Columbia University, Herbert Irving Comprehensive Cancer Center

New York, New York 10032

We've found

3 trials

at this facility

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

New York, NY

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Status: Enrolling
Updated: 11/19/2015

from

New York, NY

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

Status: Enrolling, Phase II
Updated: 12/31/1969

from

New York, NY

Use our guide to learn which trials are right for you!